GO:1901203 positive regulation of extracellular matrix assembly: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901203 describes any process that activates or increases the frequency, rate or extent of extracellular matrix assembly, a biological_process ontology term.
• Extracellular matrix assembly is a dynamic, multi-step process involving fibrillin-1, collagens, fibronectin, and proteoglycans, and its positive regulation is critical for tissue integrity.
• Dysregulated positive regulation of ECM assembly contributes to fibrosis, cancer progression, and developmental disorders such as keratoconus.
• Key molecular players include TGF-beta/Smad3 signaling, integrin-Rho GTPase pathways, and circadian regulators like BMAL1.
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect causal roles of specific genes in ECM assembly regulation.
• Targeting positive regulators of ECM assembly is a promising therapeutic strategy in oncology, fibrotic diseases, and regenerative medicine.
Description
The Gene Ontology (GO) term GO:1901203, positive regulation of extracellular matrix assembly, is a biological_process that encompasses any mechanism that activates or increases the frequency, rate, or extent of extracellular matrix (ECM) assembly. ECM assembly is the process by which cells secrete and organize structural macromolecules such as collagens, fibrillins, fibronectin, and proteoglycans into a functional network that provides mechanical support and biochemical signals. Positive regulation of this process ensures proper tissue architecture during development, wound healing, and homeostasis, but its dysregulation underlies numerous pathologies. Researchers study GO:1901203 to understand how cells control the timing and location of ECM deposition. For example, endothelial BMAL1 decline during aging destabilizes extracellular fibrillin-1, leading to bone loss, illustrating how a positive regulator of ECM assembly can be age-dependent. Similarly, Smad3 modulates stromal ECM proteins in corneal scarring after alkali injury, highlighting the TGF-beta pathway as a key positive regulator. In cancer, SPON2 promotes M1-like macrophage recruitment and inhibits hepatocellular carcinoma metastasis through integrin-Rho GTPase-Hippo pathways, demonstrating that ECM assembly regulation is intertwined with immune cell function. Because ECM assembly is fundamental to tissue mechanics and cell signaling, understanding its positive regulation has broad implications for developmental biology, cancer research, fibrosis, and regenerative medicine. This article synthesizes authoritative GO annotations and verified PubMed literature to provide a research-grade overview of GO:1901203, its molecular players, disease relevance, and experimental approaches.
positive regulation of extracellular matrix assembly At A Glance
| GO ID | GO:1901203 |
|---|---|
| GO term | positive regulation of extracellular matrix assembly |
| Ontology | biological_process |
| Synonym | activation of extracellular matrix assembly; up regulation of extracellular matrix assembly; up-regulation of extracellular matrix assembly; upregulation of extracellular matrix assembly |
| Major function | Activates or increases the frequency, rate or extent of extracellular matrix assembly |
| Related processes | Extracellular matrix organization, cell adhesion, TGF-beta signaling, integrin signaling |
| Key regulators | BMAL1, SMAD3, SPON2, fibrillin-1, collagens, fibronectin |
| Disease relevance | Fibrosis, cancer metastasis, keratoconus, bone loss, corneal scarring |
What Is GO:1901203?
GO:1901203 is defined by the Gene Ontology as any process that activates or increases the frequency, rate or extent of extracellular matrix assembly. In other words, it covers all molecular events and signaling pathways that positively regulate the construction of the ECM, a complex meshwork of proteins and polysaccharides that surrounds cells and provides structural and biochemical support.
Why Is positive regulation of extracellular matrix assembly Important in Cell Biology?
Positive regulation of extracellular matrix assembly is essential for normal development, tissue repair, and organ function. Dysregulation of this process contributes to a wide range of diseases, including fibrosis, cancer, and connective tissue disorders. Understanding the molecular mechanisms that positively regulate ECM assembly can reveal therapeutic targets for promoting tissue regeneration or inhibiting pathological ECM deposition.
• ECM assembly is required for tissue architecture and mechanical stability.
• Positive regulation ensures timely ECM deposition during wound healing and development.
• Dysregulated ECM assembly contributes to fibrosis in lung, liver, and kidney.
• ECM remodeling influences cancer cell invasion and metastasis.
• Circadian clock genes like BMAL1 regulate ECM assembly in bone, linking aging to bone loss.
• TGF-beta/Smad3 signaling is a major positive regulator of ECM protein expression.
• Integrin-Rho GTPase pathways modulate ECM assembly in immune cells.
• Genetic variants in ECM genes are associated with keratoconus.
• Targeting ECM assembly regulators can enhance immunotherapy efficacy.
• CRISPR-based models enable causal dissection of ECM regulatory networks.
What Happens During positive regulation of extracellular matrix assembly?
Initiation by signaling pathways
In simple terms: Cells receive signals that tell them to start building the matrix.
Positive regulation of ECM assembly often begins with extracellular cues such as TGF-beta, which activates SMAD3 to increase transcription of ECM genes like collagens and fibronectin. In endothelial cells, the circadian protein BMAL1 maintains fibrillin-1 stability, and its decline during aging leads to reduced ECM assembly in bone. Integrin engagement by SPON2 can also trigger Rho GTPase signaling to promote ECM remodeling.
Synthesis and secretion of ECM components
In simple terms: The cell produces and releases matrix proteins.
Once activated, cells synthesize ECM proteins including fibrillin-1, collagens, and proteoglycans. These proteins are secreted into the extracellular space. Smad3 modulates stromal ECM proteins in corneal scarring, indicating that transcriptional regulation is a key step. The availability of minerals like zinc can also influence ECM degradation and assembly, as shown in tumor models where zinc-organometallic frameworks regulate ECM degradation.
Assembly and cross-linking
In simple terms: Matrix proteins link together to form a stable network.
Secreted ECM proteins assemble into supramolecular structures. Fibrillin-1 forms microfibrils that provide a scaffold for elastin. BMAL1 decline destabilizes fibrillin-1, impairing microfibril assembly and leading to bone loss. Cross-linking enzymes and post-translational modifications further stabilize the matrix. In biofilms, a novel mineral component was discovered in the extracellular matrix, highlighting the diversity of ECM assembly mechanisms.
Feedback and remodeling
In simple terms: The matrix is constantly adjusted by cells.
ECM assembly is dynamically regulated by feedback loops. Integrin-Rho GTPase-Hippo pathways mediate SPON2-driven macrophage recruitment and inhibit hepatocellular carcinoma metastasis, showing that ECM remodeling is coupled to cell signaling. Extracellular vesicles may also contribute to ECM assembly in polycystic kidney disease, as proposed in a recent hypothesis. This feedback ensures that ECM assembly is matched to tissue needs.
Key Genes Involved in GO:1901203 positive regulation of extracellular matrix assembly
The following genes and proteins are key players in positive regulation of extracellular matrix assembly, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BMAL1 | Circadian regulator; stabilizes fibrillin-1 | Aging-related bone loss; ECM assembly in bone |
| FBN1 | Fibrillin-1; core ECM structural protein | Microfibril assembly; Marfan syndrome; bone homeostasis |
| SMAD3 | TGF-beta signaling effector; transcription factor | Corneal scarring; fibrosis; ECM gene expression |
| SPON2 | Secreted ECM protein; integrin ligand | Hepatocellular carcinoma metastasis; macrophage recruitment |
| COL1A1 | Type I collagen; major ECM component | Fibrosis; bone; tissue strength |
| COL3A1 | Type III collagen; ECM component | Wound healing; vascular integrity |
| FN1 | Fibronectin; ECM glycoprotein | Cell adhesion; ECM assembly; cancer |
| ITGB1 | Integrin beta-1; ECM receptor | Cell-ECM adhesion; signaling |
| RHOA | Rho GTPase; cytoskeletal regulator | ECM remodeling; cell migration |
| YAP1 | Hippo pathway effector | ECM stiffness; cancer progression |
| TGFB1 | Transforming growth factor beta-1 | Fibrosis; ECM production |
| MMP2 | Matrix metalloproteinase-2 | ECM degradation; cancer invasion |
| MMP9 | Matrix metalloproteinase-9 | ECM remodeling; inflammation |
| VIM | Vimentin; intermediate filament | ECM interactions; cell migration |
| ERBB4 | Receptor tyrosine kinase | Synapse development; ECM interactions |
| Vgat | Vesicular GABA transporter | Interneuron development; ECM-related |
| PKD1 | Polycystin-1; ECM-related | Polycystic kidney disease; EV hypothesis |
| PKD2 | Polycystin-2; ECM-related | Polycystic kidney disease; EV hypothesis |
How Is positive regulation of extracellular matrix assembly Regulated?
Positive regulation of ECM assembly is controlled by multiple signaling pathways. TGF-beta/Smad3 signaling is a major transcriptional regulator of ECM genes. The circadian clock protein BMAL1 regulates fibrillin-1 stability, linking ECM assembly to aging. Integrin-Rho GTPase-Hippo pathways mediate SPON2-driven ECM remodeling and immune cell recruitment. Additionally, extracellular vesicles may carry regulatory cargo that influences ECM assembly in kidney disease. Zinc availability can also modulate ECM degradation and assembly in tumor microenvironments.
positive regulation of extracellular matrix assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BMAL1 | Age-related bone loss | Endothelial-specific knockout mouse; CRISPR KO in osteoblasts |
| SMAD3 | Corneal scarring / fibrosis | Smad3 knockout mouse; corneal alkali injury model |
| SPON2 | Hepatocellular carcinoma metastasis | SPON2 knockout or overexpression in HCC cell lines; xenograft |
| FBN1 | Marfan syndrome / keratoconus | Fbn1 knock-in mouse; patient-derived fibroblasts |
| MMP2/MMP9 | Cancer ECM degradation | CRISPR knockout in tumor cells; zinc-based therapies |
Cancer and metastasis
Positive regulation of ECM assembly is frequently dysregulated in cancer. SPON2 promotes M1-like macrophage recruitment and inhibits hepatocellular carcinoma metastasis through integrin-Rho GTPase-Hippo pathways, indicating that ECM assembly regulators can suppress tumor progression. Conversely, excessive ECM deposition can promote tumor stiffness and invasion. Zinc-organometallic frameworks that regulate tumor ECM degradation can potentiate immunotherapy efficacy, highlighting the therapeutic potential of targeting ECM assembly.
Fibrosis and corneal scarring
Smad3 modulates stromal ECM proteins in corneal scarring after alkali injury, demonstrating that TGF-beta/Smad3-driven ECM assembly contributes to fibrotic scarring. Similar mechanisms operate in lung, liver, and kidney fibrosis. Understanding positive regulation of ECM assembly is therefore critical for developing anti-fibrotic therapies.
Keratoconus and connective tissue disorders
Genetic variants in ECM genes are associated with keratoconus, a progressive corneal thinning disorder. A comprehensive review of keratoconus genetics highlights the role of ECM assembly and remodeling genes in disease pathogenesis. Mutations in fibrillin-1 (FBN1) cause Marfan syndrome, a connective tissue disorder characterized by defective ECM assembly.
Bone loss and aging
Endothelial BMAL1 decline during aging leads to bone loss by destabilizing extracellular fibrillin-1, directly linking positive regulation of ECM assembly to age-related bone deterioration. This suggests that maintaining BMAL1 function or fibrillin-1 stability could be a therapeutic strategy for osteoporosis.
From positive regulation of extracellular matrix assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does BMAL1 regulate fibrillin-1 assembly in bone? | Endothelial-specific Bmal1 knockout mouse; CRISPR KO in vitro |
| How does Smad3 modulate corneal ECM? | Smad3 knockout mouse; corneal alkali injury |
| Does SPON2 promote M1 macrophage recruitment via ECM? | SPON2 knockout and overexpression in HCC cells; co-culture |
| What is the role of zinc in tumor ECM degradation? | Zinc-organometallic framework in tumor models; CRISPR KO of MMPs |
| Do extracellular vesicles carry ECM assembly regulators? | EV isolation from PKD models; CRISPR KO of PKD1/2 |
| How do genetic variants affect keratoconus ECM? | Patient-derived iPSCs; CRISPR correction of variants |
How to Study the positive regulation of extracellular matrix assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcript levels of ECM genes | Identify Smad3 targets in fibrosis |
| Proteomics | ECM protein composition and modifications | Quantify fibrillin-1 stability |
| Immunofluorescence | Localization and abundance of ECM proteins | Visualize microfibrils in bone |
| Atomic force microscopy | ECM stiffness | Assess tumor ECM remodeling |
| CRISPR knockout library | Genes required for ECM assembly | Screen for positive regulators |
| Extracellular vesicle isolation | EV cargo and function | Study PKD ECM hypothesis |
| Cell migration assay | Macrophage recruitment | SPON2 function in HCC |
Transcriptomic and proteomic profiling
RNA-seq and proteomics can identify genes and proteins differentially expressed upon positive regulation of ECM assembly. For example, Smad3-dependent changes in ECM proteins were analyzed in corneal scarring models. Mass spectrometry-based proteomics can quantify ECM composition and post-translational modifications.
Imaging ECM assembly
Immunofluorescence and electron microscopy visualize fibrillin-1 microfibrils, collagen fibers, and other ECM components. BMAL1 decline was shown to destabilize fibrillin-1 using imaging techniques. Live-cell imaging can track secretion and assembly dynamics.
Functional assays for ECM assembly
Cell adhesion assays, ECM deposition assays, and stiffness measurements (e.g., atomic force microscopy) quantify ECM assembly. SPON2-mediated macrophage recruitment was assessed using migration assays. Zinc-based ECM degradation was measured in tumor models.
Genetic screens and CRISPR libraries
CRISPR knockout libraries can systematically identify positive regulators of ECM assembly. For instance, genome-wide screens in cancer cells can reveal genes that modulate ECM deposition and immune cell recruitment. Bioinformatics analysis of screen hits can uncover pathways and networks.
How CRISPR Can Be Used to Study GO:1901203 positive regulation of extracellular matrix assembly
Knockout
CRISPR knockout of candidate positive regulators (e.g., BMAL1, SMAD3, SPON2) can abolish ECM assembly and reveal causal roles. For example, endothelial Bmal1 knockout in mice led to fibrillin-1 destabilization and bone loss. Smad3 knockout reduced ECM protein expression in corneal scarring models.
Point Mutation
Point mutations can mimic disease-associated variants in ECM genes. For instance, specific mutations in FBN1 cause Marfan syndrome; CRISPR point mutation models can recapitulate these defects and test corrective strategies. Point mutations in SMAD3 may alter its transcriptional activity.
Knock-in
Knock-in of tagged ECM proteins (e.g., fluorescently labeled fibrillin-1) allows real-time tracking of assembly. Knock-in of disease variants (e.g., keratoconus-associated SNPs) can model genetic contributions to ECM dysregulation. Knock-in of reporter genes under ECM promoters enables high-throughput screening.
Overexpression
Overexpression of positive regulators such as SPON2 or SMAD3 can enhance ECM assembly and drive pathological remodeling. SPON2 overexpression in HCC cells promoted M1 macrophage recruitment and inhibited metastasis. Overexpression of BMAL1 may protect against age-related ECM decline.
How EDITGENE Supports positive regulation of extracellular matrix assembly Research
Researchers studying positive regulation of extracellular matrix assembly-related genes often need to determine whether a candidate gene is causally involved in ECM deposition, remodeling, or disease progression. EDITGENE provides comprehensive CRISPR-based services to accelerate this research, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of extracellular matrix assembly research.
Frequently Asked Questions About positive regulation of extracellular matrix assembly
What is GO:1901203?
GO:1901203 is the Gene Ontology term for positive regulation of extracellular matrix assembly, a biological process that activates or increases the frequency, rate or extent of ECM assembly.
What genes are involved in positive regulation of extracellular matrix assembly?
Key genes include BMAL1, SMAD3, SPON2, FBN1, COL1A1, FN1, and MMPs, among others.
How does TGF-beta regulate ECM assembly?
TGF-beta activates SMAD3, which increases transcription of ECM genes like collagens and fibronectin, promoting ECM assembly.
What diseases are associated with dysregulated ECM assembly?
Fibrosis, cancer metastasis, keratoconus, Marfan syndrome, and age-related bone loss are linked to ECM assembly dysregulation.
How can CRISPR be used to study ECM assembly?
CRISPR knockout, point mutation, knock-in, and overexpression models can dissect causal roles of specific genes in ECM assembly.
What is the role of BMAL1 in ECM assembly?
BMAL1 stabilizes fibrillin-1; its decline during aging leads to destabilized ECM and bone loss.
How does SPON2 affect ECM remodeling in cancer?
SPON2 promotes M1-like macrophage recruitment and inhibits hepatocellular carcinoma metastasis via integrin-Rho GTPase-Hippo pathways.
What experimental models are used to study ECM assembly?
Models include knockout mice, CRISPR-edited cell lines, patient-derived iPSCs, and 3D ECM cultures.
What is the role of zinc in ECM degradation?
Zinc-organometallic frameworks can regulate tumor ECM degradation and potentiate immunotherapy efficacy.
How do extracellular vesicles influence ECM assembly?
Extracellular vesicles may carry regulatory cargo that affects ECM assembly in polycystic kidney disease, as hypothesized.
Conclusion
GO:1901203, positive regulation of extracellular matrix assembly, is a fundamental biological process with broad implications for development, tissue homeostasis, and disease. Key regulators such as BMAL1, SMAD3, and SPON2 have been identified through rigorous studies, and their dysregulation contributes to cancer, fibrosis, and connective tissue disorders. CRISPR-based models are indispensable for dissecting these mechanisms and developing targeted therapies. EDITGENE offers a full suite of services to support researchers in this endeavor, from knockout to library screening and bioinformatics.
References
- 1. Yin Y et al.. 2024. Endothelial BMAL1 decline during aging leads to bone loss by destabilizing extracellular fibrillin-1.. J Clin Invest 134(24) PMID: 39680455
- 2. Hogan MC et al.. 2024. An extracellular vesicle based hypothesis for the genesis of the polycystic kidney diseases.. Extracell Vesicle 4 PMID: 39886526
- 3. Zhang YL et al.. 2018. SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways.. Cancer Res 78(9):2305-2317 PMID: 29440144
- 4. Lin TW et al.. 2018. Regulation of Synapse Development by Vgat Deletion from ErbB4-Positive Interneurons.. J Neurosci 38(10):2533-2550 PMID: 29431653
- 5. Gupta S et al.. 2024. Analysis of Smad3 in the modulation of stromal extracellular matrix proteins in corneal scarring after alkali injury.. Mol Vis 30:448-464 PMID: 39959170
- 6. Barcelo-Canton RH et al.. 2025. Genetics of Keratoconus: A Comprehensive Review.. Genes (Basel) 16(10) PMID: 41153364
- 7. Keren-Paz A et al.. 2020. A brick in the wall: Discovering a novel mineral component of the biofilm extracellular matrix.. N Biotechnol 56:9-15 PMID: 31706043
- 8. Ding L et al.. 2023. Zinc-Organometallic Framework Vaccine Controlled-Release Zn(2+) Regulates Tumor Extracellular Matrix Degradation Potentiate Efficacy of Immunotherapy.. Adv Sci (Weinh) 10(27):e2302967 PMID: 37439462
